Silver Book Fact

A 2002 study found that image-guided percutaneous needle biopsies are between 3 and 7 times more cost-effective than open surgical biopsies, require a shorter procedure time, result in fewer infections, and allow earlier treatment if cancer is found.

Jelinek, James S., Mark D. Murphey, James A. Welker, Robert M. Henshaw, Mark J. Kransdorf, Barry M. Shmookler, and Martin M. Malawer. Diagnosis of Primary Bone Tumors with Image-Guided Percutaneous Biopsy: Experience with 110 tumors. Radiology. 2002; 223: 731-7. http://radiology.rsnajnls.org/cgi/content/abstract/223/3/731

Reference

Title
Diagnosis of Primary Bone Tumors with Image-Guided Percutaneous Biopsy: Experience with 110 tumors
Publication
Radiology
Publication Date
2002
Authors
Jelinek, James S., Mark D. Murphey, James A. Welker, Robert M. Henshaw, Mark J. Kransdorf, Barry M. Shmookler, and Martin M. Malawer
Pages
731-7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • There are 3 million more cancer survivors today than there were a decade ago.  
  • Gains in healthy years of life and social value from cancer R&D
     
  • Low dose CT screening for lung cancer costs less than $200 per person, and surgery for stage I lung cancer is less than 1/2 the cost of late-stage treatment.  
  • 750 cancer-fighting medicines are currently in development.  
  • Baseline lung cancer screening would lead to more than 130,000 additional survivors in 2012.